clinical trial · NCT07216313
A Drug-Drug Interaction Study of Denifanstat and Resmetirom in Healthy Adult Participants
HealthyDenifanstatResmetirom
brief summary
This is an open-label, 2-cohort study to evaluate the mutual DDI potential between denifanstat and resmetirom in healthy adult participants.
started
Sep 30, 2025
primary completion
Oct 20, 2025
completion
Oct 20, 2025
last updated
Jan 23, 2026
official title
A Phase 1, Open-Label Study to Evaluate the Mutual Drug-Drug Interaction Potential Between Denifanstat and Resmetirom in Healthy Adult Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol